PLUTO IMMUNOTHERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 17 Nov 2025)
What this means for you
Not registered yet, but its 13 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98083185
- Mark type
- Stylized text
- Filed
- 13 Jul 2023
- Published for opposition
- 30 Apr 2024
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Immunotherapeutic pharmaceutical preparations and drugs for use in cell therapy, for use in the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases, and for use in regenerative medicine
- Class 042 — Scientific and technological services: Medical, scientific, and pharmaceutical research and development in the fields of cell therapy and immunotherapeutic cell therapy
Owner
- PLUTO IMMUNOTHERAPEUTICS, INC., Los Angeles, CA, US
- PLUTO IMMUNOTHERAPEUTICS, INC., Los Angeles, CA, US
Prosecution history
- 18 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2025 — SOU EXTENSION 3 GRANTED
- 17 Nov 2025 — SOU EXTENSION 3 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2025 — SOU EXTENSION 2 GRANTED
- 16 Jun 2025 — SOU EXTENSION 2 FILED
- 16 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 1 GRANTED
- 05 Dec 2024 — SOU EXTENSION 1 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Apr 2024 — PUBLISHED FOR OPPOSITION